165 related articles for article (PubMed ID: 26492542)
1. RADIOACTIVE IODINE THERAPY WITHOUT RECENT ANTITHYROID DRUG PRETREATMENT FOR HYPERTHYROIDISM COMPLICATED BY SEVERE HYPERBILIRUBINEMIA DUE TO HEPATIC DYSFUNCTION: EXPERIENCE OF A CHINESE MEDICAL CENTER.
Ding Y; Xing J; Qiu Z; Wang Y; Zhang Y; Fang Y; Peng X; Long Y; Deng P
Endocr Pract; 2016 Feb; 22(2):173-9. PubMed ID: 26492542
[TBL] [Abstract][Full Text] [Related]
2. Pretreatment with propylthiouracil but not methimazole reduces the therapeutic efficacy of iodine-131 in hyperthyroidism.
Imseis RE; Vanmiddlesworth L; Massie JD; Bush AJ; Vanmiddlesworth NR
J Clin Endocrinol Metab; 1998 Feb; 83(2):685-7. PubMed ID: 9467593
[TBL] [Abstract][Full Text] [Related]
3. High dose of (131)I therapy for the treatment of hyperthyroidism caused by Graves' disease.
Alexander EK; Larsen PR
J Clin Endocrinol Metab; 2002 Mar; 87(3):1073-7. PubMed ID: 11889166
[TBL] [Abstract][Full Text] [Related]
4. COMBINATION OF MOLECULAR ADSORBENT RECIRCULATING SYSTEM AND RADIOIODINE FOR THE TREATMENT OF CONCURRENT HYPERTHYROIDISM AND SEVERE LIVER DYSFUNCTION: A RETROSPECTIVE COHORT STUDY.
Zhang Q; Guan Y; Xiang T; Liu S; Chen Q; Zhang Q
Endocr Pract; 2017 Feb; 23(2):141-148. PubMed ID: 27819764
[TBL] [Abstract][Full Text] [Related]
5. 131I therapy for 345 patients with refractory severe hyperthyroidism: Without antithyroid drug pretreatment.
Ding Y; Xing J; Fang Y; Wang Y; Zhang Y; Long Y
Exp Biol Med (Maywood); 2016 Feb; 241(3):290-5. PubMed ID: 26341470
[TBL] [Abstract][Full Text] [Related]
6. Sustained control of Graves' hyperthyroidism during long-term low-dose antithyroid drug therapy of patients with severe Graves' orbitopathy.
Laurberg P; Berman DC; Andersen S; Bülow Pedersen I
Thyroid; 2011 Sep; 21(9):951-6. PubMed ID: 21834677
[TBL] [Abstract][Full Text] [Related]
7. Analysis of 90 cases of antithyroid drug-induced severe hepatotoxicity over 13 years in China.
Yang J; Li LF; Xu Q; Zhang J; Weng WW; Zhu YJ; Dong MJ
Thyroid; 2015 Mar; 25(3):278-83. PubMed ID: 25384184
[TBL] [Abstract][Full Text] [Related]
8. An unusual evolution of thyroid function after therapeutic plasma exchange in Graves' disease with cholestatic jaundice: A case report.
Jin Y; Feng X; Ni H
Medicine (Baltimore); 2024 Feb; 103(8):e37074. PubMed ID: 38394504
[TBL] [Abstract][Full Text] [Related]
9. The effect of propylthiouracil on subsequent radioactive iodine therapy in Graves' disease.
Hancock LD; Tuttle RM; LeMar H; Bauman J; Patience T
Clin Endocrinol (Oxf); 1997 Oct; 47(4):425-30. PubMed ID: 9404440
[TBL] [Abstract][Full Text] [Related]
10. Appearance of severe jaundice after radiometabolical treatment of thyrotoxicosis.
Babini G; Gurioli L; Rizzi R; Bertello P
J Endocrinol Invest; 1999 Mar; 22(3):209-11. PubMed ID: 10219889
[TBL] [Abstract][Full Text] [Related]
11. Antithyroid drug therapy in hyperthyroidism. Recurrence, hypothyroidism and thyroid antibodies.
Stege R
Acta Chir Scand Suppl; 1980; 501():1-130. PubMed ID: 6163270
[No Abstract] [Full Text] [Related]
12. Outcome of pediatric Graves' disease after treatment with antithyroid medication and radioiodine.
Ward L; Huot C; Lambert R; Deal C; Collu R; Van Vliet G
Clin Invest Med; 1999 Aug; 22(4):132-9. PubMed ID: 10497711
[TBL] [Abstract][Full Text] [Related]
13. Thionamide-induced Agranulocytosis: A Retrospective Analysis of 36 Patients With Hyperthyroidism.
Zhu D; Zhang S; Cao X; Xia Q; Zhang Q; Deng D; Gao S; Yu H; Liu Y; Zhou H; Tao F; Sun X
Endocr Pract; 2021 Dec; 27(12):1183-1188. PubMed ID: 34216800
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of clinical characteristics of patients with hyperthyroidism combined with liver injury].
Sheng QJ; Ding Y; Zhang C; Han C; Li YW; Fan YX; Dou XG
Zhonghua Gan Zang Bing Za Zhi; 2021 Oct; 29(10):967-971. PubMed ID: 34814390
[No Abstract] [Full Text] [Related]
15. Two-day thionamide withdrawal prior to radioiodine uptake sufficiently increases uptake and does not exacerbate hyperthyroidism compared to 7-day withdrawal in Graves' disease.
Kubota S; Ohye H; Yano G; Nishihara E; Kudo T; Ito M; Fukata S; Amino N; Kuma K; Miyauchi A
Endocr J; 2006 Oct; 53(5):603-7. PubMed ID: 16896267
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of Antithyroid Drug-Induced Agranulocytosis in Patients with Hyperthyroidism: A Retrospective Analysis of 114 Cases in a Single Institution in China Involving 9690 Patients Referred for Radioiodine Treatment Over 15 Years.
Yang J; Zhu YJ; Zhong JJ; Zhang J; Weng WW; Liu ZF; Xu Q; Dong MJ
Thyroid; 2016 May; 26(5):627-33. PubMed ID: 26867063
[TBL] [Abstract][Full Text] [Related]
17. Is long-term methimazole therapy as effective as radioiodine for treating hyperthyroidism?
Toft AD
Nat Clin Pract Endocrinol Metab; 2005 Nov; 1(1):14-5. PubMed ID: 16929359
[No Abstract] [Full Text] [Related]
18. The Long-Term Outcome of Treatment for Graves' Hyperthyroidism.
Sjölin G; Holmberg M; Törring O; Byström K; Khamisi S; de Laval D; Abraham-Nordling M; Calissendorff J; Lantz M; Hallengren B; Filipsson Nyström H; Wallin G
Thyroid; 2019 Nov; 29(11):1545-1557. PubMed ID: 31482765
[No Abstract] [Full Text] [Related]
19. Antithyroid drug treatment for graves' disease in children: a long-term retrospective study at a single institution.
Ohye H; Minagawa A; Noh JY; Mukasa K; Kunii Y; Watanabe N; Matsumoto M; Suzuki M; Yoshihara A; Ito K; Ito K
Thyroid; 2014 Feb; 24(2):200-7. PubMed ID: 23926918
[TBL] [Abstract][Full Text] [Related]
20. [Two cases of serious hepatic injury caused by antithyroid drugs].
Grzywa M; Orłowska-Florek R; Grzywa-Celińska A
Endokrynol Pol; 2009; 60(5):396-400. PubMed ID: 19885811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
